logo
Plus   Neg
Share
Email

Perrigo Launches AB Rated Generic Version Of Epiduo Gel

Perrigo Company plc (PRGO) said it has received final approval from the U.S. Food and Drug Administration and has launched an AB rated generic version of Epiduo (adapalene and benzoyl peroxide) Gel, 0.1%/2.5%.

Epiduo Gel is indicated for the topical treatment of acne vulgaris in patients 9 years of age and older. Market sales of Epiduo Gel over the last 12 months were approximately $164 million, according to IMS Health.

Separately, Perrigo Company announced it has received final approval from the U.S. Food and Drug Administration for the generic version of Estrace Cream (estradiol vaginal cream, USP, 0.01%). This product will be marketed by Perrigo's partner, Impax Laboratories, Inc. (IPXL), and is currently expected to launch in the second quarter of this year.

For comments and feedback contact: editorial@rttnews.com

Business News

Follow RTT
>